Phase 2 Trial of Intensive Chemo-immunotherapy with Carfilzomib Lenalidomide Dexamethasone and Daratumumab for Relapsed/Refractory Myeloma in the context of salvage autologous hematopoietic cell transplantation.

Brief description of study

The purpose of this research study is to test if there are any good and bad effects of giving a combination of study drugs before and after autologous stem cell transplant. In an autologous stem cell transplant, the stem cells in your body that produce blood are removed from the body and then returned after treatment with chemotherapy.

If you are registered as a volunteer, please login to the dashboard to send referrals.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.